A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder
Clinical trial NCT03093025 · TERMINATED
Trial details
- NCT number
- NCT03093025
- Sponsor
- Taisho Pharmaceutical R&D Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-03
- Primary completion
- 2018-11-08
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.